Drug intelligence / Profile preview

shuanghuanglian tablets

Development stage
Unknown
Lead developer
Fusen Pharmaceutical
Modality
Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
Administration
Oral
01

Overview

Shuanghuanglian Tablets is a traditional Chinese patent medicine (TCPM) formulated from three key herbal ingredients: Lonicera japonica (Japanese honeysuckle), Scutellaria baicalensis (Baikal skullcap), and Forsythia suspensa (weeping forsythia). It is widely used in China for clearing heat, detoxifying the body, and expelling wind-heat pathogens. The formulation is primarily indicated for the treatment of acute upper respiratory tract infections, the common cold, fever, cough, and sore throat. Its active chemical constituents, including baicalin, chlorogenic acid, and forsythoside A, exhibit broad-spectrum antibacterial, anti-inflammatory, and antiviral properties.

Other names
Shuanghuanglian Tabletsshuanghuanglian双黄连片
02

Targets

BCL-2 (BCL-2 family)MAPK14 (p38 mitogen-activated protein kinase alpha)NeuraminidaseGSEC (Gamma-Secretase Complex)IL-6 (Interleukin 6)

Beyond the preview

Go deeper on shuanghuanglian tablets.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on shuanghuanglian tablets.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call